Author

N. Navone

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:human· 3 Research Focus:cancer & tumor microenvironment· 2 Assay:metabolomics· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Assay:DNA methylation· 1

Frequent Co-Authors

A. Aparicio· 1 shared A. Delcourt· 1 shared A. G. Hoang· 1 shared A. Jones· 1 shared A. K. Jain· 1 shared A. Petcherski· 1 shared A. S. Divakaruni· 1 shared A. S. Goldstein· 1 shared

Activity by Year

2022-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 14 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Aparicio

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Androgen receptor inhibition induces metabolic reprogramming and increased reliance on oxidative mitochondrial metabolism in prostate cancer

P. Crowell, J. Giafaglione, A. Jones, N. Nunley, T. Hashimoto, A. Delcourt, A. Petcherski, M. Bernard, R. R. Huang, J.-Y. Low, N. Matulionis, X. Guan, N. Navone, J. Alumkal, M. Haffner, , A. S. Goldstein

This study shows that androgen receptor inhibition in prostate cancer cells shifts metabolism to oxidative mitochondrial pathways and increases sensitivity to complex I inhibitors.

Cell Reports · Oct 1, 2023Peer-reviewedCancer Biology

Role of Adenosine Deaminase in Prostate Cancer Progression

C. Charles, S. M. Lloyd, D. W. B. Piyarathna, J. Gohlke, U. Rasaily, V. Putluri, B. W. Simons, A. Zaslavsky, S. Nallandhighal, N. Palanisamy, N. Navone, J. A. Jones, M. M. Ittmann, N. Putluri, D. R. Rowley, , A. Sreekumar

This study identifies adenosine deaminase (ADA) as a driver of prostate cancer progression and metastasis through metabolomics and in vitro/in vivo experiments.

bioRxiv · Aug 9, 2023 · PreprintCancer Biology

KDM4A promotes the progression of neuroendocrine prostate cancer

C. S. L. Mak, M. Zhu, X. Liang, F. Wang, F. Yuan, A. G. Hoang, X. Song, P. Shepherd, D. Liang, J. Suh, B. Pradhan, J. Park, M. Zhang, E. Metzger, R. Schule, , G. Wang

This study identifies KDM4A as a key driver of neuroendocrine prostate cancer progression and shows that targeting KDM4A inhibits tumor growth in preclinical models.

bioRxiv · May 14, 2022 · PreprintCancer Biology